Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
Manufactured by
guangzhou biotron technolongy co.,ltd
China
Guangzhou Biotron Technology Co., Ltd. is a Chinese manufacturer of in vitro diagnostic (IVD) products, specializing in molecular diagnostics (multiplex PCR platforms), point-of-care testing (POCT), pathology diagnostics, and tumor liquid biopsy systems. Their product lines include respiratory pathogen detection panels, HPV testing, tuberculosis IGRA assays, and circulating tumor cell (CTC) detection systems. The company also offers CDMO services for diagnostic product development.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
Diatech Pharmacogenetics srl
Italy · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 3 relevant products
64 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 97 closest product alternatives
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
Diatech Pharmacogenetics srl · Italy
Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
94 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products